I stated things would get better for CDMO once new management was in place and they shifted..
The only thing that matters would be the shifting of protein pathways, in order to restore an optimal immune response and those PS Targeting based Biomarkers are worth Billions ...
The only thing new management seems to be good at is having their Ampersand Capital backed bag holders use some of the knowledge and create new CDMOs for business growth...sort of a pay day, where they hope some Avid CDMO shareholders accept breadcrumbs
I see there are still lots of undisclosed happenings going on ....where researchers stealing data, vials, research ..Biomarkers etc and more to come that will prove the old BOD did not stand a chance with corruption of some
Amazing how many Alan List and Thomas Sellers types are out there that accept monies to not disclose how valuable PS Targeting truly is ...
News 
Market Data 
Discover 
